SLC31A1 and osteosarcoma: PTBP1 affects the expression level of SLC31A1 by binding to its mRNA, thereby affecting the uptake of cisplatin by CISR osteosarcoma cells and regulating the sensitivity of CISR osteosarcoma cells to cisplatin.